CA17129 – Catalysing transcriptomics research in cardiovascular disease
CardioRNA COST Action CA17129 is a collaborative pan-European network of multidisciplinary researchers, clinicians, and industrial partners aiming to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and further the translation of experimental data into usable applications to improve personalized medicine in this field.
Successful first EU-CardioRNA Digital meeting: CardioRNA LIVE! 7-10 SeptemberSeptember 15, 2020
In the autumn of 2020 we were unable to meet in person in Zagreb. Instead, we took the opportunity to connect our members from all corners of the earth with the first EU-CardioRNA COST Action Digital meeting: CardioRNA LIVE! We welcomed 120 speakers and attendees over four days of talks and discussion, representing 34 countries […]
New CardioRNA review out in IJMS on the role and interaction of non-coding RNA mechanisms in the brain-heart axisSeptember 6, 2020
Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease Keywords: Parkinson’s disease; brain; heart; biomarkers; non-coding RNAs; data science; systems; biomedicine; artificial intelligence Access the full article here: ijms-21-06513
Frontiers in CardioVascular Biomedicine 2021, Budapest22 - 25 April 2021
The Frontiers in CardioVascular Biomedicine, run by the ESC council for Basic Cardiovascular Science, meetings are increasingly considered as one of the most relevant exchange platforms for basic and translational cardiovascular biology. Our EU-CardioRNA COST Action Chair Yvan Devaux and WG3 Leader Monika Stoll will Chair a session entitled “Non-coding RNAs in cardiovascular diseases”, which […]